These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 15983634)

  • 1. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM; Eesa NN; Yacoub MH; Elsman RM
    Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP; Trabandt A; Grobe N; Werle E
    Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus.
    Julkunen H; Salonen EM; Walle TK; Miettinen A
    Scand J Rheumatol; 2005; 34(2):122-4. PubMed ID: 16095007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
    Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
    Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
    Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
    Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.
    Biesen R; Dähnrich C; Rosemann A; Barkhudarova F; Rose T; Jakob O; Bruns A; Backhaus M; Stöcker W; Burmester GR; Schlumberger W; Egerer K; Hiepe F
    Arthritis Res Ther; 2011 Feb; 13(1):R26. PubMed ID: 21329504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
    Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
    Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
    Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
    Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients.
    Ghirardello A; Doria A; Zampieri S; Tarricone E; Tozzoli R; Villalta D; Bizzaro N; Piccoli A; Gambari PF
    J Autoimmun; 2004 May; 22(3):235-40. PubMed ID: 15041044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.